Department of Pancreato-Biliary Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, Guangdong, PR China.
Department of Pancreato-Biliary Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, Guangdong, PR China.
Asian J Surg. 2022 Feb;45(2):712-717. doi: 10.1016/j.asjsur.2021.07.039. Epub 2021 Aug 9.
There lacks a predictive model for overall survival (OS) of node-negative perihilar cholangiocarcinoma (PHC). This study aimed at developing and validating a prognostic nomogram to predict OS of node-negative PHC after resection.
We established a nomogram via multivariate regression analysis by using the design cohort (n = 410, obtained from Surveillance, Epidemiology, and End Results database), and its external verification was done in the validation cohort (n = 100, the First Affiliated Hospital of Sun Yat-sen University). Predictive accuracy of the nomogram was assessed by concordance-index (C-index), calibration curves, and decision curve analysis (DCA). Performance of the nomogram was compared with the American Joint Committee on Cancer (AJCC) staging system.
Multivariate regression analysis revealed that age, tumor grade, and the count of examined lymph nodes were independent prognostic factors for OS of node-negative PHC. The nomogram had a C-index of 0.603 and 0.626 in design cohort and validation cohort, respectively, which was better than that of AJCC staging system (both p < 0.05). The calibration curves showed good consistency between actual and nomogram-predicted OS probabilities. DCA showed that nomogram had better clinical usefulness. Furthermore, the nomogram-predicted scores could stratify the patients into three risk groups, and patients in higher risk group had worse prognosis than those in lower risk group (all p < 0.05).
The proposed nomogram had a better prognostic accuracy than the AJCC staging system in predicting postoperative OS of node-negative PHC. It was helpful to guide the adjuvant therapeutic strategies for node-negative PHC.
目前缺乏用于预测阴性淋巴结肝门周围胆管癌(PHC)总生存期(OS)的模型。本研究旨在建立并验证一种预测阴性淋巴结肝门周围胆管癌术后 OS 的预后列线图。
我们通过多变量回归分析,利用设计队列(n=410,来自监测、流行病学和最终结果数据库)建立了一个列线图,并在验证队列(n=100,中山大学第一附属医院)中进行了外部验证。通过一致性指数(C 指数)、校准曲线和决策曲线分析(DCA)评估列线图的预测准确性。并将该列线图与美国癌症联合委员会(AJCC)分期系统进行比较。
多变量回归分析显示,年龄、肿瘤分级和检查的淋巴结数量是阴性淋巴结肝门周围胆管癌 OS 的独立预后因素。该列线图在设计队列和验证队列中的 C 指数分别为 0.603 和 0.626,均优于 AJCC 分期系统(均 p<0.05)。校准曲线显示实际和列线图预测 OS 概率之间具有良好的一致性。DCA 表明列线图具有更好的临床实用性。此外,该列线图预测评分可以将患者分为三个风险组,且风险较高的患者预后较风险较低的患者差(均 p<0.05)。
与 AJCC 分期系统相比,该列线图在预测阴性淋巴结肝门周围胆管癌术后 OS 方面具有更好的准确性。它有助于指导阴性淋巴结肝门周围胆管癌的辅助治疗策略。